Guidelines on Management of Cancer Pain: Bibliography
American Society of
Anesthesiologists
1. Adams F, Cruz
L, Deachman MJ, Zamora E: Focal subdermal toxicity with subcutaneous opioid
infusion in patients with cancer pain. Journal of Pain & Symptom Management
4:31-33, 1989
2. Aguilar JL,
Montes A, Samper D, Roca G, Vidal F: Interpleural analgesia through a DuPen
catheter for lung cancer pain. Cancer 70:2621-2623, 1992
3. Ahlgren FI,
Ahlgren MB: Epidural administration of opiates by a new device. Pain 31:353-357,
1987
4. Ali NM, Hanna
N, Hoffman JS: Percutaneous epidural catheterization for intractable pain in
terminal cancer patients. Gynecologic Oncology 32:22-25, 1989
5. Ali NM,
Hoffman JS: Tolerance during long-term administration of intrathecal morphine.
Connecticut Medicine 53:266-268, 1989
6. Allum WH,
Mack P, Priestman TJ, Fielding JW: Radiotherapy for pain relief in locally
recurrent colorectal cancer. Annals of the Royal College of Surgeons of England
69:220-221, 1987
7. Amano K,
Kawamura H, Tanikawa T, Kawabatake H, Iseki H, Iwata Y: Bilateral versus
unilateral percutaneous high cervical cordotomy as a surgical method of pain
relief. Acta Neurochirurgica - Supplementum 52:143-145, 1991
8. Andersen HB,
Kjaergard J, Eriksen J: Subcutaneously implanted injection system for epidural
administration. Acta Anaesthesiologica Scandinavica 30:473-476, 1986
9. Andersen PE,
Cohen JI, Everts EC, Bedder MD, Burchiel KJ: Intrathecal narcotics for relief
of pain from head and neck cancer. Archives of Otolaryngology -- Head &
Neck Surgery 117:1277-1280, 1991
10. Arbit E,
Galicich JH, Burt M, Mallya K: Modified open thoracic rhizotomy for treatment
of intractable chest wall pain of malignant etiology. Ann Thorac Surg
48:820-823, 1989
11. Arner S,
Arner B: Differential effects of epidural morphine in the treatment of
cancer-related pain. Acta Anaesthesiologica Scandinavica 29:32-36, 1985
12. Ashburn MA,
Fine PG, Stanley TH: Oral transmucosal fentanyl citrate for the treatment of
breakthrough cancer pain: a case report. Anesthesiology 71:615-617, 1989
13. Ashby MA,
Fleming BG, Brooksbank M, Rounsefell B, Runciman WB, Muirden N, Smith M:
Description of a mechanistic approach to pain management in advanced cancer.
Preliminary report. Pain 51:153-161, 1992
14. Bach F,
Larsen BH, Rohde K, Borgesen SE, Gjerris F, Boge-Rasmussen T, Rasmusson B,
Stjernholm P, Sorensen PS: Metastatic spinal cord compression. Occurrence,
symptoms, clinical presentations and prognosis in 398 patients with spinal cord
compression. Acta Neurochirurgica 107:37-43, 1990
15. Baines M,
Oliver DJ, Carter RL: Medical management of intestinal obstruction in patients
with advanced malignant disease: a clinical and pathological study. Lancet
ii:990-993, 1985
16. Banning A,
Sjogren P, Henriksen H: Treatment outcome in a multidisciplinary cancer pain
clinic [see comments]. Pain 47:129-34; discussion 127, 1991
17. Barak F,
Werner A, Walach N, et al: The palliative efficacy of a single high dose of
radiation in treatment of symptomatic osseous metastases. Int J Radiat Oncol
Biol Phys 13:1233-1235, 1987(Abstract)
18. Barber J:
Hypnosis as a psychological technique in the management of cancer pain. Cancer
Nursing 1:361-363, 1978
19. Barkwell DP:
Ascribed meaning: a critical factor in coping and pain attenuation in patients
with cancer-related pain. Journal of Palliative Care 7:5-14, 1991
20. Batzdorf U,
Brechner VL: Management of pain associated with the pancoaste syndrome.
American Journal of Surgery 137:638-646, 1979
21. Baumann TJ,
Batenhorst RL, Graves DA, Foster TS, Bennett RL: Patient-controlled analgesia
in the terminally ill cancer patient. Drug Intelligence & Clinical Pharmacy
20:297-301, 1986
22. Bedder MD,
Burchiel K, Larson A: Cost analysis of two implantable narcotic delivery
systems. Journal Of Pain And Symptom Management 6:368-373, 1991
23. Bengtsson M,
Lofstrom JB: Nerve block in pancreatic pain. Acta Chirurgica Scandinavica
156:285-291, 1990
24. Benson RC,
Jr., Hasan SM, Jones AG, Schlise S: External beam radiotherapy for palliation
of pain from metastatic carcinoma of the prostate. Journal of Urology
127:69-71, 1982
25. Benzon HT:
Convulsions secondary to intravascular phenol: a hazard of celiac plexus block.
Anesthesia and Analgesia 58:150-151, 1979
26. Berde CB,
Fischel N, Filardi JP, Coe CS, Grier HE, Bernstein SC: Caudal epidural morphine
analgesia for an infant with advanced neuroblastoma: report of a case. Pain
36:219-223, 1989
27. Bigler D,
Christensen CB, Eriksen J, Jensen NH: Morphine, morphine-6-glucuronide and
morphine-3-glucuronide concentrations in plasma and cerebrospinal fluid during
long-term high-dose intrathecal morphine administration. Pain 41:15-18, 1990
28. Birnbaum PL,
Mercer CD: Laser fulguration for palliation of rectal tumours. Canadian Journal
of Surgery 33:299-301, 1990
29. Blanchard J,
Menk E, Ramamurthy S, Hoffman J: Subarachnoid and epidural calcitonin in
patients with pain due to metastatic cancer. Journal of Pain & Symptom
Management 5:42-45, 1990
30. Boersma FP,
Buist AB, Thie J: Epidural pain treatment in the northern Netherlands.
Organizational and treatment aspects. Acta Anaesthesiologica Belgica
38:213-216, 1987
31. Boersma FP,
Noorduin H, Vanden Bussche G: Epidural sufentanil for cancer pain control in
outpatients. Regional Anesthesia 14:293-297, 1989
32. Bosch DA:
Stereotactic rostral mesencephalotomy in cancer pain and deafferentation pain.
A series of 40 cases with follow-up results [see comments]. Journal of
Neurosurgery 75:747-751, 1991
33. Breivik H,
Rennemo F: Clinical evaluation of combined treatment with methadone and
psychotropic drugs in cancer patients. Acta Anaesthesiologica Scandinavica
Supplementum 74:135-140, 1982
34. Brown DL: A
retrospective analysis of neurolytic celiac plexus block for nonpancreatic
intra-abdominal cancer pain. Regional Anesthesia 14:63-65, 1989
35. Brown DL,
Bulley CK, Quiel EL: Neurolytic celiac plexus block for pancreatic cancer pain.
Anesthesia & Analgesia 66:869-873, 1987
36. Bruera E,
Brenneis C, Michaud M, Bacovsky R, Chadwick S, Emeno A: Use of the subcutaneous
route for the administration of narcotics in patients with cancer pain. Cancer
62:407-411, 1988
37. Bruera E,
Brenneis C, Michaud M, Chadwick S, MacDonald RN: Continuous sc infusion of
narcotics using a portable disposable device in patients with advanced cancer.
Cancer Treatment Reports 71:635-637, 1987
38. Bruera E,
Brenneis C, Michaud M, Macmillan K, Hanson J, MacDonald RN: Patient-controlled
subcutaneous hydromorphone versus continuous subcutaneous infusion for the
treatment of cancer pain. Journal of the National Cancer Institute
80:1152-1154, 1988
39. Bruera E,
Brenneis C, Paterson AH, MacDonald RN: Use of methylphenidate as an adjuvant to
narcotic analgesics in patients with advanced cancer. Journal of Pain &
Symptom Management 4:3-6, 1989
40. Bruera E,
Carraro S, Roca E, Barugel M, Chacon R: Double-blind evaluation of the effects
of mazindol on pain, depression, anxiety, appetite, and activity in terminal
cancer patients. Cancer Treatment Reports 70:295-298, 1986
41. Bruera E, Fainsinger
R, Moore M, Thibault R, Spoldi E, Ventafridda V: Local toxicity with
subcutaneous methadone. Experience of two centers [see comments]. Pain
45:141-143, 1991
42. Bruera E,
Legris MA, Kuehn N, Miller MJ: Hypodermoclysis for the administration of fluids
and narcotic analgesics in patients with advanced cancer. Journal of Pain &
Symptom Management 5:218-220, 1990
43. Bruera E,
MacDonald N, Brenneis C, Simpson I, LeGatt D: Metoclopramide infusion with a
disposable pump. Annals of Internal Medicine 104(6):8961986
44. Bruera E,
Macmillan K, Hanson J, MacDonald RN: Palliative care in a cancer center:
results in 1984 versus 1987. Journal of Pain & Symptom Management 5:1-5,
1990
45. Bruera E,
Macmillan K, Kuehn N, Hanson J, MacDonald RN: A controlled trial of megestrol
acetate on appetite, caloric intake, nutritional status, and other symptoms in
patients with advanced cancer. Cancer 66:1279-1282, 1990
46. Bruera E,
Macmillan K, Pither J, MacDonald RN: Effects of morphine on the dyspnea of
terminal cancer patients. Journal of Pain & Symptom Management 5:341-344,
1990
47. Bruera E,
Miller MJ: Non-cardiogenic pulmonary edema after narcotic treatment for cancer
pain. Pain 39:297-300, 1989
48. Bruera E,
Miller MJ, Macmillan K, Kuehn N: Neuropsychological effects of methylphenidate
in patients receiving a continuous infusion of narcotics for cancer pain. Pain
48:163-166, 1992
49. Bruera E,
Schoeller T, Fainsinger RL, Kastelan C: Custom-made suppositories of methadone
for severe cancer pain. Journal Of Pain And Symptom Management 7:372-374, 1992
50. Bruera E,
Schoeller T, Montejo G: Organic hallucinosis in patients receiving high doses
of opiates for cancer pain. Pain 48:397-399, 1992
51. Bruera ED,
Chadwick S, Bacovsky R, MacDonald N: Continuous subcutaneous infusion of
narcotics using a portable disposable pump. Journal Of Palliative Care 1:46-47,
1985
52. Bryant DD,
DeWitty RL, Jr., Dennis GC: The Infusaid pump in the management of intractable
cancer pain. Journal of the National Medical Association 79:305-311, 1987
53. Buy JN, Moss
AA, Singler RC: CT guided celiac plexus and splanchnic nerve neurolysis.
Journal Of Computer Assisted Tomography 6:315-319, 1982
54. Campbell CF,
Mason JB, Weiler JM: Continuous subcutaneous infusion of morphine for the pain
of terminal malignancy. Annals Of Internal Medicine 98:51-52, 1983
55. Campora E,
Merlini L, Pace M, Bruzzone M, Luzzani M, Gottlieb A: The incidence of
narcotic-induced emesis. Journal of Pain & Symptom Management 6:428-430,
1991
56. Caputi CA,
Busca G, Fogliardi F, Giugliano F: Evaluation of tolerance in long-term
treatment of cancer pain with epidural morphine. International Journal of
Clinical Pharmacology, Therapy, & Toxicology 21:587-590, 1983
57. Carey PO,
Lippert MC: Treatment of painful prostatic bone metastases with oral etidronate
disodium. Urology 32:403-407, 1988
58. Carl P,
Crawford ME, Ravlo O, Bach V: Longterm treatment with epidural opioids. A
retrospective study comprising 150 patients treated with morphine chloride and
buprenorphine. Anaesthesia 41:32-38, 1986
59. Carlisle DW,
Smith KA, Frank E, Meyers FJ: Intraventricular morphine administered by hospice
nurses to a patient in intractable pain. American Journal of Hospice Care
6(4):36-39, 1989
60. Carlson RW,
Borrison RA, Sher HB, Eisenberg PD, Mowry PA, Wolin EM: A multiinstitutional
evaluation of the analgesic efficacy and safety of ketorolac tromethamine,
acetaminophen plus codeine, and placebo in cancer pain. Pharmacotherapy
10:211-216, 1990
61. Cassileth
PA, Lusk EJ, Torri S, Di Nubile N, Gerson SL: Anti-emetic efficacy of
dexamethasone therapy in patients receiving cancer chemotherapy. Archives of
Internal Medicine 143:1347-1349, 1983
62. Caute B,
Monsarrat B, Gouarderes C, Verdie JC, Lazorthes Y, Cros J: CSF morphine levels
after lumbar intrathecal administration of isobaric and hyperbaric solutions
for cancer pain. Pain 32:141-146, 1988
63. Chan A,
Woodruff RK: Palliative care in a general teaching hospital. 1. Assessment of
needs. Medical Journal of Australia 155:597-599, 1991
64. Choi CR, Ha
YS, Ahn MS, Lee JS, Song JU: Intraventricular or epidural injection of morphine
for severe pain. Neurochirurgia 32:180-183, 1989
65. Citron ML,
Johnston-Early A, Boyer M, Krasnow SH, Hood M, Cohen MH: Patient-controlled
analgesia for severe cancer pain. Archives of Internal Medicine 146:734-736,
1986
66. Citron ML,
Johnston-Early A, Fossieck BE, Jr., Krasnow SH, Franklin R, Cohen MH: Safety
and efficacy of continuous intravenous morphine for severe cancer pain.
American Journal of Medicine 77:199-204, 1984
67. Citron ML,
Kalra JM, Seltzer VL, Chen S, Hoffman M, Walczak MB: Patient-controlled
analgesia for cancer pain: a long-term study of inpatient and outpatient use.
Cancer Investigation 10:335-341, 1992
68. Cleeland CS,
Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA: Pain and its treatment
in outpatients with metastatic cancer. New England Journal of Medicine
330:592-596, 1994
69. Cobb CA,
French BN, Smith KA: Intrathecal morphine for pelvic and sacral pain caused by
cancer. Surgical Neurology 22:63-68, 1984
70. Collins TM,
Ash DV, Close HJ: An evaluation of the palliative role of radiotherapy in
inoperable carcinoma of the bronchus. Clin Radiol 39:284-286, 1988
71. Cook PR,
Campbell FN, Puddy BR: Pituitary alcohol injection for cancer pain. Use in a
district general hospital. Anaesthesia 39:540-545, 1984
72. Coombs DW,
Maurer LH, Saunders RL, Gaylor M: Outcomes and complications of continuous
intraspinal narcotic analgesia for cancer pain control. Journal of Clinical
Oncology 2:1414-1420, 1984
73. Coombs DW,
Saunders RL, Fratkin JD, Jensen LE, Murphy CA: Continuous intrathecal
hydromorphone and clonidine for intractable cancer pain. Journal of
Neurosurgery 64:890-894, 1986
74. Coombs DW,
Saunders RL, Gaylor MS, Block AR, Colton T, Harbaugh R, Mroz W: Relief of
continuous chronic pain by intraspinal narcotics infusion via an implanted
reservoir. JAMA 250:2336-2339, 1983
75. Corssen G,
Holcomb MC, Moustapha I, Langford K, Vitek JJ, Ceballos R: Alcohol-induced
adenolysis of the pituitary gland: a new approach to control of intractable
cancer pain. Anesthesia & Analgesia 56:414-421, 1977
76. Coyle N: A
model of continuity of care for cancer patients with chronic pain. Medical
Clinics Of North America 71:259-270, 1987
77. Coyle N:
Continuity of care for the cancer patient with chronic pain. Cancer
63:2289-2293, 1989
78. Coyle N,
Mauskop A, Maggard J, Foley KM: Continuous subcutaneous infusions of opiates in
cancer patients with pain. Oncology Nursing Forum 13:53-57, 1986
79. Coyle N,
Monzillo E, Losalzo M, Farkas C, Massie MJ, Foley KM: A model of continuity of
care for cancer patients with pain and neuro-oncologic complications. Cancer
Nursing 8:111-119, 1985
80. Crul BJ,
Delhaas EM: Technical complications during long-term subarachnoid or epidural
administration of morphine in terminally ill cancer patients: a review of 140
cases. Regional Anesthesia 16:209-213, 1991
81. Cubeddu LX,
Pendergrass K, Ryan T, York M, Burton G, Meshad M, Ciociola AA: Efficacy of
oral ondansetron, a selective antagonist of 5-HT3 receptors, in the treatment
of nausea and vomiting associated with cyclophosphamide-based chemotherapies.
Ondansetron Study Group [see comments]. American Journal of Clinical Oncology
17:137-146, 1994
82. De Conno F,
Caraceni A, Aldrighetti L, Magnani G, Ferla G, Comi G: Paraplegia following
coeliac plexus block. Pain 55:383-385, 1993
83. De Conno F,
Ripamonti C, Sbanotto A, Barletta L, Zecca E, Martini C: A clinical study on
the use of codeine, oxycodone, dextropropoxyphene, buprenorphine, and
pentazocine in cancer pain. Journal of Pain & Symptom Management 6:423-427,
1991
84. de Cuyper C,
Goeteyn M: Systemic contact dermatitis from subcutaneous hydromorphone. Contact
Dermatitis 27:220-223, 1992
85. de
Leon-Casasola OA, Kent E, Lema MJ: Neurolytic superior hypogastric plexus block
for chronic pelvic pain associated with cancer. Pain 54:145-151, 1993
86.
DeChristoforo R, Corden BJ, Hood JC, Narang PK, Magrath IT: High-dose morphine
infusion complicated by chlorobutanol-induced somnolence. Annals Of Internal
Medicine 98:335-336, 1983
87. Dennis GC,
DeWitty R: Management of intractable pain in cancer patients by implantable
morphine infusion systems. Journal of the National Medical Association
79:939-944, 1987
88. Dennis GC,
DeWitty RL: Long-term intraventricular infusion of morphine for intractable
pain in cancer of the head and neck. Neurosurgery 26:404-7; discussion 407,
1990
89. Denobile J,
Chester W, Etienne HB, Ghosh BC: Long-term epidural pain relief using a totally
implantable access system. Journal of Surgical Oncology 43:92-93, 1990
90. Devulder J:
PCA and cancer pain. Acta Anaesthesiologica Belgica 43:53-56, 1992
91. Downing JE,
Busch EH, Stedman PM: Epidural morphine delivered by a percutaneous epidural
catheter for outpatient treatment of cancer pain [see comments]. Anesthesia
& Analgesia 67:1159-1161, 1988
92. Drexel H,
Dzien A, Spiegel RW, Lang AH, Breier C, Abbrederis K, Braunsteiner H: Treatment
of severe cancer pain by low-dose continuous subcutaneous morphine. Pain
36:169-176, 1989
93. Driessen JJ,
de Mulder PH, Claessen JJ, van Diejen D, Wobbes T: Epidural administration of
morphine for control of cancer pain: long-term efficacy and complications.
Clinical Journal of Pain 5:217-222, 1989
94. Du Pen SL,
Kharasch ED, Williams A, Peterson DG, Sloan DC, Krembs AW: Chronic epidural
bupivacaine-opioid infusion in intractable cancer pain [see comments]. Pain
49:293-300, 1992
95. Du Pen SL,
Peterson DG, Bogosian AC, Ramsey DH, Larson C, Omoto M: A new permanent
exteriorized epidural catheter for narcotic self-administration to control
cancer pain. Cancer 59:986-993, 1987
96. Du Pen SL,
Williams AR: Management of patients receiving combined epidural morphine and
bupivacaine for the treatment of cancer pain. Journal of Pain & Symptom
Management 7:125-127, 1992
97. Du Pen SL,
Williams AR: The dilemma of conversion from systemic to epidural morphine: a
proposed conversion tool for treatment of cancer pain. Pain 56:113-118, 1994
98. Duthie AM,
Ingham V, Dell AE, Dennett JE: Pituitary cryoablation. The results of treatment
using a transphenoidal cryoprobe. Anaesthesia 38:448-451, 1983
99. Eisenach JC,
Rauck RL, Buzzanell C, Lysak SZ: Epidural clonidine analgesia for intractable
cancer pain: phase I. Anesthesiology 71:647-652, 1989
100. Engquist A,
Chraemmer Jorgensen B, Andersen HB: Epidural morphine induced catatonia. Lancet
ii:984, 1980
101. Erdine S,
Aldemir T: Long-term results of peridural morphine in 225 patients. Pain
45:155-159, 1991
102. Eriksson
MB, Lindahl S, Nyquist JK: Experimental cutaneous pain thresholds and tolerance
in clinical analgesia with epidural morphine. Acta Anaesthesiologica
Scandinavica 26:654-657, 1982
103. Esposito S,
Bruni P, Delitala A, Canova A, Hernandez R, Callovini GM: Therapeutic approach
to the Pancoast pain syndrome. Applied Neurophysiology 48:262-266, 1985
104. Esposito S,
Delitala A: Transoval administration of opiates into trigeminal cistern for
cancer pain. Preliminary report. Neurochirurgia 34:116-118, 1991
105. Estap'e J,
Vinolas N, Gonz'alez B, Ingl'es F, Bofill T, Guzm'an MC, Tarrag'o E: Ketorolac,
a new non-opioid analgesic: a double-blind trial versus pentazocine in cancer
pain. Journal Of International Medical Research 18:298-304, 1990
106. Ettinger
DS, Vitale PJ, Trump DL: Important clinical pharmacologic considerations in the
use of methadone in cancer patients. Cancer Treatment Reports 63:457-459, 1979
107. Fainsinger
R, Miller MJ, Bruera E, Hanson J, MacEachern T: Symptom control during the last
week of life on a palliative care unit. Journal of Palliative Care 7:5-11, 1991
108. Felsoory A,
Crue BL: Results of 19 years experience with sacral rhizotomy for perineal and
perianal cancer pain. Pain 2:431-433, 1976
109. Fernandez
F, Adams F, Holmes VF: Analgesic effect of alprazolam in patients with chronic,
organic pain of malignant origin. Journal of Clinical Psychopharmacology
7:167-169, 1987
110. Ferris FD,
Kerr IG, De Angelis C, Sone M, Hume S: Inpatient narcotic infusions for
patients with cancer pain. Journal of Palliative Care 6:51-59, 1990
111. Ferris FD,
Kerr IG, Sone M, Marcuzzi M: Transdermal scopolamine use in the control of
narcotic-induced nausea. Journal of Pain & Symptom Management 6:389-393,
1991
112. Filshie J,
Golding S, Robbie DS, Husband JE: Unilateral computerised tomography guided
coeliac plexus block: a technique for pain relief. Anaesthesia 38:498-503, 1983
113. Findler G,
Olshwang D, Hadani M: Continuous epidural morphine treatment for intractable
pain in terminal cancer patients. Pain 14:311-315, 1982
114. Fineman SP:
Long-term post-thoracotomy cancer pain management with interpleural
bupivacaine. Anesthesia & Analgesia 68:694-697, 1989
115. Fishman B,
Loscalzo M: Cognitive-behavioral interventions in management of cancer pain:
Principles and applications. Med Clin North Am 71:271-287, 1987
116. Fleming U:
Relaxation therapy for far-advanced cancer. Practitioner 229:471-475, 1985
117. Follett KA,
Hitchon PW, Piper J, Kumar V, Clamon G, Jones MP: Response of intractable pain
to continuous intrathecal morphine: a retrospective study. Pain 49:21-25, 1992
118.
Francaviglia N, Silvestro C, Carta F, Davini V, Perria C, Cipolla PV:
Subarachnoid buprenorphine administered by implantable micropumps. Acta
Neurochirurgica 102:62-68, 1990
119. Frank F,
Fabrizi AP, Gaist G, Weigel K, Mundinger F: Stereotactic mesencephalotomy
versus multiple thalamotomies in the treatment of chronic cancer pain
syndromes. Applied Neurophysiology 50:314-318, 1987
120. Fujita Y:
CT-guided neurolytic splanchnic nerve block with alcohol. Pain 55:363-366, 1993
121. Gildenberg
PL: Myelotomy and percutaneous cervical cordotomy for the treatment of cancer
pain. Applied Neurophysiology 47:208-215, 1984
122. Gildenberg
PL, Hirshberg RM: Limited myelotomy for the treatment of intractable cancer
pain. Journal of Neurology, Neurosurgery & Psychiatry 47:94-96, 1984
123. Glare P,
Lickiss JN: Unrecognized constipation in patients with advanced cancer: a
recipe for therapeutic disaster. Journal of Pain & Symptom Management 7:369-371,
1992
124. Glynn CJ,
Lloyd JW, Folkhard S: Ventilatory response to intractable pain. Pain
11:201-211, 1981
125. Goisis A,
Gorini M, Ratti R, Luliri P: Application of a WHO protocol on medical therapy
for oncologic pain in an internal medicine hospital. Tumori 75:470-472, 1989
126. Gonski A,
Sackelariou R: Cryohypophysectomy for the relief of pain in malignant disease.
Medical Journal of Australia 140:140-142, 1984
127. Gonzales
GR, Coyle N: Treatment of cancer pain in a former opioid abuser: fears of the
patient and staff and their influence on care. Journal of Pain & Symptom
Management 7:246-249, 1992
128. Gonzales
GR, Elliott KJ, Portenoy RK, Foley KM: The impact of a comprehensive evaluation
in the management of cancer pain. Pain 47:141-144, 1991
129. Goucke R:
Continuous intrathecal analgesia with opioid/local anaesthetic mixture for
cancer pain. Anaesthesia & Intensive Care 21:222-223, 1993
130. Gourlay GK,
Cherry DA, Cousins MJ: A comparative study of the efficacy and pharmacokinetics
of oral methadone and morphine in the treatment of severe pain in patients with
cancer. Pain 25:297-312, 1986
131. Gourlay GK,
Plummer JL, Cherry DA, Onley MM, Parish KA, Wood MM: Comparison of intermittent
bolus with continuous infusion of epidural morphine in the treatment of severe
cancer pain. Pain 47:135-140, 1991
132. Greenberg
HS, Taren J, Ensminger WD, Doan K: Benefit from and tolerance to continuous
intrathecal infusion of morphine for intractable cancer pain. Journal Of
Neurosurgery 57:360-364, 1982
133. Grochow L,
Sheidler V, Grossman S, Green L, Enterline J: Does intravenous methadone
provide longer lasting analgesia than intravenous morphine? A randomized,
double-blind study [see comments]. Pain 38:151-157, 1989
134. Grond S,
Zech D, Lynch J, Diefenbach C, Schug SA, Lehmann KA: Validation of World Health
Organization guidelines for pain relief in head and neck cancer. A prospective
study. Annals of Otology, Rhinology & Laryngology 102:342-348, 1993
135. Grond S,
Zech D, Schug SA, Lynch J, Lehmann KA: The importance of non-opioid analgesics
for cancer pain relief according to the guidelines of the World Health
Organization. International Journal Of Clinical Pharmacology Research
11:253-260, 1991
136. Grond S,
Zech D, Schug SA, Lynch J, Lehmann KA: Validation of World Health Organization
guidelines for cancer pain relief during the last days and hours of life.
Journal of Pain & Symptom Management 6:411-422, 1991
137. Gye RS,
Stanworth PA, Stewart JA, Adams CB: Cryohypophysectomy for bone pain of
metastatic breast cancer. Pain 6:201-206, 1979
138. Haaga JR,
Kori SH, Eastwood DW, Borkowski GP: Improved technique for CT-guided celiac
ganglia block. Ajr American Journal Of Roentgenology 142:1201-1204, 1984
139. Hankemeir
U: Neurolytic celiac plexus block for cancer-related upper abdominal pain using
the unilateral puncture technique and lateral position (Abstr). Pain supp
4:s135, 1987
140. Hanks GW,
Twycross RG, Bliss JM: Controlled release morphine tablets: a double-blind
trial in patients with advanced cancer. Anaesthesia 42:840-844, 1987
141. Hanna MH,
et al: Efficacy and CSF pharmacokinetics of intrathecal morphine-6-clucuronide:
comparison with morphine. British Journal of Anaesthesia 64:547-550, 1990
142. Hardy PA,
Wells JC: Patient-controlled intrathecal morphine for cancer pain. A method
used to assess morphine requirements and bolus doses. Clinical Journal of Pain
6:57-59, 1990
143. Hashimoto
Y, Takarada M, Tanioka H, Rigor BM: Treatment of cancer pain of the head and
neck by continuous intravenous infusion of high-dose morphine: report of two
cases. Journal of Oral & Maxillofacial Surgery 48:398-400, 1990
144. Hassenbusch
SJ, Pillay PK, Barnett GH: Radiofrequency cingulotomy for intractable cancer
pain using stereotaxis guided by magnetic resonance imaging. Neurosurgery
27:220-223, 1990
145. Hassenbusch
SJ, Pillay PK, Magdinec M, Currie K, Bay JW, CovingtonEC., Tomaszewski MZ:
Constant infusion of morphine for intractable cancer pain using an implanted
pump [see comments]. Journal of Neurosurgery 73:405-409, 1990
146. Heim ME,
Romer W, Queisser W: Clinical experience with levonantradol hydrochloride in
the prevention of cancer chemotherapy-induced nausea and vomiting. Journal of
Clinical Pharmacology 21:86S-89S, 1981
147. Hendrickx
P, Abou Hatem R, Nicaise C: Implantable injection port for epidural opiates
self-administration. Acta Anaesthesiologica Belgica 35 Suppl:279-284, 1984
148. Hensley JR:
Continuous SC morphine for cancer pain. American Journal Of Nursing 91:98-101,
1991
149. Herbst LH,
Strause LG: Transdermal fentanyl use in hospice home-care patients with chronic
cancer pain. Journal of Pain & Symptom Management 7:S54-S57, 1992
150. Higginson
I, McCarthy M: Measuring symptoms in terminal cancer: are pain and dyspnoea
controlled? Journal of the Royal Society of Medicine 82:264-267, 1989
151. Hill HF,
Jacobson RC, Coda BA, Mackie AM: A computer-based system for controlling plasma
opioid concentration according to patient need for analgesia. Clinical
Pharmacokinetics 20:319-330, 1991
152. Hiraga K,
Mizuguchi T, Takeda F: The incidence of cancer pain and improvement of pain
management in Japan. Postgraduate Medical Journal 67 Suppl 2:S14-25, 1991
153. Hirsh LF,
Thanki A, Nowak T: Sudden loss of pain control with morphine pump due to
catheter migration. Neurosurgery 17:965-967, 1985
154. Hoffman M,
Provatas A, Lyver A, Kanner R: Pain management in the opioid-addicted patient
with cancer. Cancer 68:1121-1122, 1991
155. Hogan Q,
Haddox JD, Abram S, Weissman D, Taylor ML, Janjan N: Epidural opiates and local
anesthetics for the management of cancer pain [see comments]. Pain 46:271-279,
1991
156. Hogberg T,
Rabow L, Rosenberg P, Simonsen E: The use of chordotomy to treat pain from
gynecologic cancer. European Journal of Gynaecological Oncology 10:337-340,
1989
157. Hutchinson
H, Leedham G, Knight A: Continuous subcutaneous analgesia and antiemetics in
domiciliary terminal care. Lancet 2:1279, 1981
158. Inkpen T:
Metoclopramide-induced extrapyramidal syndromes. Journal Of Palliative Care
9:33-34, 1993
159. Inturrisi
CE, Portenoy RK, Max MB, Colburn WA, Foley KM: Pharmacokinetic-pharmacodynamic
relationships of methadone infusions in patients with cancer pain. Clinical
Pharmacology And Therapeutics 47:565-577, 1990
160. Ischia S,
Ischia A, Polati E, Finco G: Three posterior percutaneous celiac plexus block
techniques. A prospective, randomized study in 61 patients with pancreatic
cancer pain. Anesthesiology 76:534-540, 1992
161. Jones J,
Gough D: Coeliac plexus block with alcohol for relief of upper abdominal pain
due to cancer. Annals of the Royal College of Surgeons of England 59:46-49,
1977
162. Joss RA,
Galeazzi RL, Bischoff A, Do DD, Goldhirsch A, Brunner KW: Levonantradol, a new
antiemetic with a high rate of side-effects for the prevention of nausea and
vomiting in patients receiving cancer chemotherapy. Cancer Chemotherapy &
Pharmacology 9:61-64, 1982
163. Kalso E,
Vainio A: Morphine and oxycodone hydrochloride in the management of cancer
pain. Clinical Pharmacology And Therapeutics 47:639-646, 1990
164. Kalso E,
Vainio A, Mattila MJ, Rosenberg PH, Seppala T: Morphine and oxycodone in the
management of cancer pain: plasma levels determined by chemical and
radioreceptor assays. Pharmacology & Toxicology 67:322-328, 1990
165. Kane RL,
Berstein L, Wales J, Rothenberg R: Hospice effectiveness in controlling pain.
JAMA 253:2683-2686, 1985
166. Kanpolat Y,
Akyar S, Caglar S, Unlu A, Bilgic S: CT-guided percutaneous selective
cordotomy. Acta Neurochirurgica 123:92-96, 1993
167. Kaplan BZ,
Krishnamurthy U, Nori D: Opiate desensitization in a terminally ill cancer
patient with pain: physician assisted succor. American Journal of Hospice &
Palliative Care 11:34-39, 1994
168. Karnofsky
DA, Abelmann WH, Craver LF: The use of the nitrogen mustards in the palliative
treatment of carcinoma. Cancer 1:634, 1948
169. Katz ER,
Kellerman J, Ellenberg L: Hypnosis in the reduction of acute pain and distress
in children with cancer. Journal of Pediatric Psychology 12:379-394, 1987
170. Katz J, Levin
AB: Treatment of diffuse metastatic cancer pain by instillation of alcohol into
the sella turcica. Anesthesiology 46:115-121, 1977
171. Kerr IG,
Sone M, Deangelis C, Iscoe N, MacKenzie R, Schueller T: Continuous narcotic
infusion with patient-controlled analgesia for chronic cancer pain in
outpatients. Annals of Internal Medicine 108:554-557, 1988
172. King H,
Xiao CS, Wooten DJ: Prolongation of epidural bupivacaine analgesia with
glycerin. Canadian Journal Of Anaesthesia 40:431-434, 1993
173. Kiss I,
Muller H, Abel M: The McGill Pain Questionnaire--German version. A study on
cancer pain. Pain 29:195-207, 1987
174. Klein DS,
Klein PW: Intermittent interpleural injection of bupivacaine and
methylprednisolone for analgesia in metastatic thoracic neoplasm. Clinical
Journal Of Pain 7:232-236, 1991
175. Koerner ME:
Using hypnosis to relieve pain of terminal cancer. Hypnosis Q 20:39-46, 1977
176. Korevaar
WC: Transcatheter thoracic epidural neurolysis using ethyl alcohol.
Anesthesiology 69:989-993, 1988
177. Korsten HH,
Ackerman EW, Grouls RJ, van Zundert AA, Boon WF, Bal F, Ribot JG, Hoefsloot F,
Slooff JL: Long-lasting epidural sensory blockade by n-butyl-p-aminobenzoate in
the terminally ill intractable cancer pain patient. Anesthesiology 75:950-960,
1991
178. Krames ES,
Gershow J, Glassberg A, Kenefick T, Lyons A, Taylor P: Continuous infusion of
spinally administered narcotics for the relief of pain due to malignant
disorders. Cancer 56:696-702, 1985
179. Krantz T,
Christensen CB: Respiratory depression after intrathecal opioids. Report of a
patient receiving long-term epidural opioid therapy. Anaesthesia 42:168-170,
1987
180. Kuperman
AS, Krieger AJ, Rosomoff HL: Respiratory function after cervical cordotomy.
Chest 59(2):128-132, 1971
181. Kuttner L,
Bowman M, Teasdale M: Psychological treatment of distress, pain, and anxiety
for young children with cancer. Journal of Developmental & Behavioral
Pediatrics 9:374-381, 1988
182. Kuzucu EY,
Derrick WS, Wilber SA: Control of intractable pain with subarachnoid alcohol
block. Jama 195:541-544, 1966
183. Lahuerta J,
Lipton S, Wells JC: Percutaneous cervical cordotomy: results and complications
in a recent series of 100 patients. Annals of the Royal College of Surgeons of
England 67:41-44, 1985
184. Lang AH,
Abbrederis K, Dzien A, Drexel H: Treatment of severe cancer pain by continuous
infusion of subcutaneous opioids. Recent Results in Cancer Research 121:51-57,
1991
185. LaRossa JT,
Strong MS, Melby JC: Endocrinologically incomplete transethmoidal trans-sphenoidal
hypophysectomy with relief of bone pain in breast cancer. New England Journal
Of Medicine 298:1332-1335, 1978
186. Lazarus H,
Fitzmartin RD, Goldenheim PD: A multi-investigator clinical evaluation of oral
controlled-release morphine (MS Contin tablets) administered to cancer
patients. Hospice Journal 6:1-15, 1990
187. Lazarus HM,
Bryson JC, Lemon E, Pritchard JF, Blumer J: Antiemetic efficacy and
pharmacokinetic analyses of the serotonin antagonist ondansetron (GR 38032F)
during multiple-day chemotherapy with cisplatin prior to autologous bone marrow
transplantation. Journal Of The National Cancer Institute 82:1776-1778, 1990
188. Lazorthes
Y, Verdie JC, Bastide R, Lavados A, Descouens D: Spinal versus intraventricular
chronic opiate administration with implantable drug delivery devices for cancer
pain. Applied Neurophysiology 48:234-241, 1985
189. Leavens ME,
Hill CSJ, Cech DA, Weyland JB, Weston, J-S: Intrathecal and intraventricular
morphine for pain in cancer patients: initial study. Journal Of Neurosurgery
56:241-245, 1982
190. Lee TL,
Kumar A, Baratham G: Intraventricular morphine for intractable craniofacial
pain. Singapore Medical Journal 31:273-276, 1990
191. Lehr VT,
Renaud EA: High transdermal fentanyl requirements in a patient with chronic
cancer pain. Annals of Pharmacotherapy 27:575-578, 1993
192. Lema MJ,
Myers DP, De Leon-Casasola O, Penetrante R: Pleural phenol therapy for the
treatment of chronic esophageal cancer pain. Regional Anesthesia 17:166-170,
1992
193. Leung JW, Bowen-Wright
M, Aveling W, Shorvon PJ, Cotton PB: Coeliac plexus block for pain in
pancreatic cancer and chronic pancreatitis. British Journal of Surgery
70:730-732, 1983
194. Levin AB,
Katz J, Benson RC, Jones AG: Treatment of pain of diffuse metastatic cancer by
stereotactic chemical hypophysectomy: long term results and observations on
mechanism of action. Neurosurgery 6:258-262, 1980
195. Levy MH:
Integration of pain management into comprehensive cancer care. Cancer
63:2328-2335, 1989
196. Levy MH, Rosen
SM, Kedziera P: Transdermal fentanyl: seeding trial in patients with chronic
cancer pain. Journal of Pain & Symptom Management 7:S48-S50, 1992
197. Levy S,
Jacobs S, Johnson J, et al: Transdermal fentanyl: pain and quality of life
effects. Proceedings of the American Society of Clinical Oncologists 7:292,
1988(Abstract)
198. Lifshitz S,
DeBacker LJ, Buchsbaum JS: Subarachnoid phenol block for pain relief in
gynecologic malignancy. Obstet Gynecol 48:316-320, 1976
199. Lin PM,
Gildenberg PL, Polakoff PP: An anterior approach to percutaneous lower cervical
cordotomy. Journal of Neurosurgery 36:553-560, 1966
200. Lipton S,
Miles J, Williams N, Jones NB: Pituitary injection of alcohol for widespread
cancer pain. Pain 5:73-82, 1978
201. Lobato RD,
Madrid JL, Fatela LV, Rivas JJ, Reig E, Lamas E: Intraventricular morphine for
control of pain in terminal cancer patients. Journal of Neurosurgery
59:627-633, 1983
202. Loeser JD:
Dorsal rhizotomy for the relief of chronic pain. Journal of Neurosurgery
36:745-750, 1972
203. Longo WE,
Ballantyne GH, Bilchik AJ, Modlin IM: Advanced rectal cancer. What is the best
palliation? Diseases of the Colon & Rectum 31:842-847, 1988
204. Madrid JL,
Fatela LV, Lobato RD, Gozalo A: Intrathecal therapy: rationale, technique,
clinical results. Acta Anaesthesiologica Scandinavica Supplementum 85:60-67,
1987
205. Maher RM:
Intrathecal chlocresol in the treatment of pain in cancer. Lancet 1:965-967,
1963
206. Maloney CM,
Kesner RK, Klein G, Bockenstette J: The rectal administration of MS Contin:
clinical implications of use in end stage cancer. American Journal Of Hospice
Care 6:34-35, 1989
207. Massimo L,
Haupt R, Zamorani ME: Control of pain with sublingual buprenorphine in children
with cancer. European Paediatric Haemotology & Oncology 2:224,
1985(Abstract)
208. Matthiessen
HV: Pain treatment in gynaecological cancer. Postgraduate Medical Journal 67
Suppl 2:S26-30, 1991
209. Maves TJ,
Barcellos WA: Management of cancer pain with transdermal fentanyl: phase IV
trial, University of Iowa. Journal of Pain & Symptom Management 7:S58-S62,
1992
210. Max MB,
Inturrisi CE, Kaiko RF, Grabinski PY, Li CH, Foley KM: Epidural and intrathecal
opiates: cerebrospinal fluid and plasma profiles in patients with chronic
cancer pain. Clinical Pharmacology And Therapeutics 38:631-641, 1985
211. McKegney
FP, Bailey LR, Yates JW: Prediction and management of pain in patients with
advanced cancer. Gen Hosp Psychiatry 3:95-101, 1981
212. Mercadante
S: Celiac plexus block versus analgesics in pancreatic cancer pain. Pain
52:187-192, 1993
213. Mercadante
S, Maddaloni S, Roccella S, Salvaggio L: Predictive factors in advanced cancer
pain treated only by analgesics. Pain 50:151-155, 1992
214. Minotti V,
Patoia L, Roila F, Basurto C, Tonato M, Pasqualucci V, Maresca V, Del Favero A:
Double-blind evaluation of analgesic efficacy of orally administered
diclofenac, nefopam, and acetylsalicylic acid (ASA) plus codeine in chronic
cancer pain. Pain 36:177-183, 1989
215. Miser AW,
Davis DM, Hughes CS, Mulne AF, Miser JS: Continuous subcutaneous infusion of
morphine in children with cancer. American Journal of Diseases of Children
137:383-385, 1983
216. Miser AW,
Miser JS, Clark BS: Continuous intravenous infusion of morphine sulfate for
control of severe pain in children with terminal malignancy. Journal Of
Pediatrics 96:930-932, 1980
217. Miser AW,
Moore L, Green R: Prospective study of continuous intravenous and subcutaneous
morphine infusions for therapy-related or cancer-related pain in children and
young adults with cancer. Clinical Journal of Pain 2:101-106, 1986
218. Miser AW,
Narang PK, Dothage JA, Young RC, Sindelar W, Miser JS: Transdermal fentanyl for
pain control in patients with cancer. Pain 37:15-21, 1989
219. Moertel CG,
Ahmann DL, Taylor WF, Schwartau N: Relief of pain by oral medications. A
controlled evaluation of analgesic combinations. Jama 229:55-59, 1974
220. Moertel CG,
Schutt AJ, Reitmeier RJ, Hahn RG: Corticosteroid therapy of preterminal
gastrointestinal cancer. Cancer 33:1607-1609, 1974
221. Moulin DE,
Johnson NG, Murray-Parsons N, Geoghegan MF, Goodwin VA: Subcutaneous narcotic
infusions for cancer pain: treatment outcome and guidelines for use [see
comments]. Canadian Medical Association Journal 146:891-897, 1992
222. Moulin DE,
Kreeft JH, Murray-Parsons N, Bouquillon AI: Comparison of continuous
subcutaneous and intravenous hydromorphone infusions for management of cancer
pain [see comments]. Lancet 337:465-468, 1991
223. Moulin DE,
Max MB, Kaiko RF, Inturrisi CE, Maggard J, Yaksh TL: The analgesic efficacy of
intrathecal D-Ala2-D-Leu5-enkephalin in cancer patients with chronic pain. Pain
23:213-221, 1985
224. Mullin V:
Brachial plexus block with phenol for painful arm associated with pancoast's
syndrome. Anesthesiology 53:431-433, 1980
225. Nahata MC,
Miser AW, Miser JS: Analgesic plasma concentrations of morphine in children
with terminal malignancy receiving a continuous subcutaneous infusion of
morphine sulphate to control severe pain. Pain 18:109-114, 1984
226. Nelson KA,
Walsh TD: Metoclopramide in anorexia caused by cancer-associated dyspepsia
syndrome (CADS). Journal Of Palliative Care 9:14-18, 1993
227. Nitescu P,
Appelgren L, Linder LE, Sjoberg M, Hultman E, Curelaru I: Epidural versus
intrathecal morphine-bupivacaine: assessment of consecutive treatments in
advanced cancer pain. Journal of Pain & Symptom Management 5:18-26, 1990
228. Noda J,
Umeda S, Arai T, Harima A, Mori K: Continuous subcutaneous infusion of
buprenorphine for cancer pain control. Clinical Journal Of Pain 5:147-152, 1989
229. Nurchi G:
Use of intraventricular and intrathecal morphine in intractable pain associated
with cancer. Neurosurgery 15:801-803, 1984
230. Obbens EA,
Hill CS, Leavens ME, Ruthenbeck SS, Otis F: Intraventricular morphine administration
for control of chronic cancer pain. Pain 28:61-68, 1987
231. Ohlsson L,
Rydberg T, Eden T, Persson Y, Thulin L: Cancer pain relief by continuous
administration of epidural morphine in a hospital setting and at home. Pain
48:349-353, 1992
232. Olness K:
Imagery (self-hypnosis) as adjunct therapy in childhood cancer: clinical
experience with 25 patients. American Journal of Pediatric Hematology-Oncology
3:313-321, 1981
233. Onofrio BM,
Yaksh TL: Long-term pain relief produced by intrathecal morphine infusion in 53
patients. Journal of Neurosurgery 72:200-209, 1990
234. Onofrio BM,
Yaksh TL, Arnold PG: Continuous low-dose intrathecal morphine administration in
the treatment of chronic pain of malignant origin. May Clin Proc 56:516-520,
1981
235. Osborne R,
Thompson P, Joel S, Trew D, Patel N, Slevin M: The analgesic activity of
morphine-6-glucuronide. British Journal of Clinical Pharmacology 34:130-138,
1992
236. Oyama T,
Fukushi S, Jin T: Epidural beta-endorphin in treatment of pain. Canadian Anaesthetists
Society Journal 29:24-26, 1982
237. Pannuti F,
Rossi AP, Iafelice G, Marraro D, Camera P, Cricca A, Burroni P, Lapucci L,
Fruet F: Control of chronic pain in very advanced cancer patients with morphine
hydrochloride administered by oral, rectal and sublingual route. Clinical
report and preliminary results on morphine pharmacokinetics. Pharmacological
Research Communications 14:369-380, 1982
238. Papo I,
Visca A: Phenol rhizotomy in the treatment of cancer pain. Anesthesia and
Analgesia 53:993-997, 1974
239. Patt RB,
Jain S: Long-term management of a patient with perineal pain secondary to
rectal cancer. Journal of Pain & Symptom Management 5:127-128, 1990
240. Patt RB,
Hogan LA: Transdermal fentanyl for chronic cancer pain: detailed case reports
and the influence of confounding factors. Journal of Pain & Symptom
Management 7:S51-S53, 1992
241. Penn RD,
Paice JA: Chronic intrathecal morphine for intractable pain. Journal of
Neurosurgery 67:182-186, 1987
242. Penn RD,
Paice JA, Gottschalk W, Ivankovich AD: Cancer pain relief using chronic
morphine infusion. Early experience with a programmable implanted drug pump.
Journal of Neurosurgery 61:302-306, 1984
243. Pfeifer BL,
Sernaker HL, Ter Horst UM: Pain scores and ventilatory and circulatory sequelae
of epidural morphine in cancer patients with and without prior narcotic
therapy. Anesthesia & Analgesia 67:838-842, 1988
244. Pfeifer BL,
Sernaker HL, Ter Horst UM, Porges SW: Cross-tolerance between systemic and
epidural morphine in cancer patients. Pain 39:181-187, 1989
245. Pilon RN,
Baker AR: Chronic pain control by means of an epidural catheter: report of a
case with description of the method. Cancer 37:903-905, 1976
246. Plancarte
R, Amescua C, Patt RB, Aldrete JA: Superior hypogastric plexus block for pelvic
cancer pain. Anesthesiology 73:236-239, 1990
247. Plummer JL,
Cherry DA, Cousins MJ, Gourlay GK, Onley MM, Evans KH: Long-term spinal
administration of morphine in cancer and non-cancer pain: a retrospective
study. Pain 44:215-220, 1991
248. Poletti CE,
Cohen AM, Todd DP, Ojemann RG, Sweet WH, Zervas NT: Cancer pain relieved by
long-term epidural morphine with permanent indwelling systems for
self-administration. Journal Of Neurosurgery 55:581-584, 1981
249. Popiela T,
Lucchi R, Giongo F: Methylprednisolone as palliative therapy for female
terminal cancer patients. Eur J Cancer Clin Oncol 25:1823-1829, 1989
250. Portenoy
RK, Moulin DE, Rogers A, Inturrisi CE, Foley KM: I.v. infusion of opioids for
cancer pain: clinical review and guidelines for use. Cancer Treatment Reports
70:575-581, 1986
251. Portenoy
RK, Southam MA, Gupta SK, Lapin J, Layman M, Inturrisi CE: Transdermal fentanyl
for cancer pain. Repeated dose pharmacokinetics. Anesthesiology 78:36-43, 1993
252. Puglisi G,
Garagiola U: Pirprofen and pentazocine in the treatment of cancer pain. Curr
Ther Res 45:333-338, 1989(Abstract)
253. Redd WH,
Jacobsen PB, Die Trill M, Dermatis H, McEvoy M, Holland JC:
Cognitive/attentional distraction in the control of conditioned nausea in pediatric
cancer patients receiving chemotherapy. Journal Of Consulting And Clinical
Psychology 55:391-395, 1987
254. Richlin DM,
Jamron LM, Novick NL: Cancer pain control with a combination of methadone,
amitriptyline, and non-narcotic analgesic therapy: a case series analysis.
Journal of Pain & Symptom Management 2:89-94, 1987
255. Rocco AG,
Chan V, Iacobo C: An algorithm for the treatment of pain in advanced cancer.
Hospice J 5(3/4):93-103, 1989
256. Rodrigues
N, Pereira ER: Tramadol in cancer pain. Current Therapeutic Research
46:1142-1148, 1989
257.
Rodriquez-Bigas M, Petrelli NJ, Herrera L, West C: Intrathecal phenol rhizotomy
for management of pain in recurrent unresectable carcinoma of the rectum. Surg
Gynecol Obstet 173:41-44, 1991
258. Rogers AG:
The use of continuous subcutaneous infusions of narcotics in chronic cancer
pain. Journal of Pain & Symptom Management 2:167-168, 1987
259. Rogers AG:
Home intravenous opioid therapy in a toddler with advanced cancer. Journal of
Pain & Symptom Management 4:230-231, 1989
260. Roila F,
Tonato M, Cognetti F: Prevention of CDDP induced emesis: a double blind
multi-center randomized crossover study comparing ondansetron and ondansetron +
dexamethasone. J Clin Oncol 9:675-678, 1991
261. Rosas GM,
Bruera E: Palliative care in Mexico: celiac-plexus block for incidental
visceral pain. Journal of Palliative Care 9:35-36, 1993(Abstract)
262. Rosomoff
HL: Bilateral percutaneous cervical radiofrequency cordotomy. Journal of
Neurosurgery 31:41-46, 1969
263. Rosomoff
HL, Krieger AJ, Kuperman AS: Effects of percutaneous cervical cordotomy on
pulmonary function. Journal of Neurosurgery 31:620-627, 1969
264. Salmon JB,
Finch PM, Lovegrove FT, Warwick A: Mapping the spread of epidural phenol in
cancer pain patients by radionuclide admixture and epidural scintigraphy.
Clinical Journal of Pain 8:18-22, 1992
265. Samuelsson
H, Ekman R, Hedner T: CSF neuropeptides in cancer pain: effects of spinal
opioid therapy. Acta Anaesthesiologica Scandinavica 37:502-508, 1993
266. Samuelsson
H, Hedner T: Pain characterization in cancer patients and the analgetic
response to epidural morphine. Pain 46:3-8, 1991
267. Samuelsson
H, Hedner T, Venn R, Michalkiewicz A: CSF and plasma concentrations of morphine
and morphine glucuronides in cancer patients receiving epidural morphine. Pain
52:179-185, 1993
268. Samuelsson
H, Nordberg G, Hedner T, Lindqvist J: CSF and plasma morphine concentrations in
cancer patients during chronic epidural morphine therapy and its relation to
pain relief. Pain 30:303-310, 1987
269. Sandouk P,
Serrie A, Urtizberea M, Debray M, Got P, Scherrmann JM: Morphine
pharmacokinetics and pain assessment after intracerebroventricular
administration in patients with terminal cancer. Clinical Pharmacology And
Therapeutics 49:442-448, 1991
270. Saris SC,
Silver JM, Vieira JFS, Nashold BS, Jr. Sacrococcygeal rhizotomy for perineal
pain. Neurosurgery 19:789-793, 1986
271. Schoeffler
P, Pichard E, Ramboatiana R, Joyon D, Haberer JP: Bacterial meningitis due to
infection of a lumbar drug release system in patients with cancer pain. Pain
25:75-77, 1986
272. Schug SA,
Zech D, Dorr U: Cancer pain management according to WHO analgesic guidelines.
Journal of Pain & Symptom Management 5:27-32, 1990
273. Schug SA,
Zech D, Grond S, Jung H, Meuser T, Stobbe B: A long-term survey of morphine in
cancer pain patients. Journal of Pain & Symptom Management 7:259-266, 1992
274. Schultheiss
R, Schramm J, Neidhardt J: Dose changes in long- and medium-term intrathecal
morphine therapy of cancer pain. Neurosurgery 31:664-9; discussion 669, 1992
275. Sharp KW,
Stevens EJ: Improving palliation in pancreatic cancer: intraoperative celiac
plexus block for pain relief. Southern Medical Journal 84:469-471, 1991
276. Shaves M,
Barnhill D, Bosscher J, Remmenga S, Hahn M, Park R: Indwelling epidural
catheters for pain control in gynecologic cancer patients. Obstetrics And
Gynecology 77:642-644, 1991
277. Shetter AG,
Hadley MN, Wilkinson E: Administration of intraspinal morphine sulfate for the
treatment of intractable cancer pain. Neurosurgery 18:740-747, 1986
278. Shir Y,
Shapira SS, Shenkman Z, Kaufman B, Magora F: Continuous epidural methadone
treatment for cancer pain. Clinical Journal of Pain 7:339-341, 1991
279. Simon NL,
Orr JW, Jr., Hatch KD, Shingleton HM: Lower extremity edema due to deep vein
thrombosis in patients with recurrent cervix cancer. Gynecologic Oncology
19:30-33, 1984
280. Singler RC:
An improved technique for alcohol neurolysis of the celiac plexus.
Anesthesiology 56:137-141, 1982
281. Sjoberg M,
Appelgren L, Einarsson S, Hultman E, Linder LE, Nitescu P: Long-term
intrathecal morphine and bupivacaine in "refractory" cancer pain. I.
Results from the first series of 52 patients. Acta Anaesthesiologica
Scandinavica 35:30-43, 1991
282. Sjoberg M,
Karlsson PA, Nordborg C, Wallgren A, Nitescu P, AppelgrenL., Linder LE,
Curelaru I: Neuropathologic findings after long-term intrathecal infusion of
morphine and bupivacaine for pain treatment in cancer patients [see comments].
Anesthesiology 76:173-186, 1992
283. Sjoberg M,
Nitescu P, Appelgren L, Curelaru I: Long-term intrathecal morphine and
bupivacaine in patients with refractory cancer pain. Results from a
morphine:bupivacaine dose regimen of 0.5:4.75 mg/ml. Anesthesiology 80:284-297,
1994
284. Sjogren P,
Banning A: Pain, sedation and reaction time during long-term treatment of
cancer patients with oral and epidural opioids. Pain 39:5-11, 1989
285. Sloan PA:
Neuropathic cancer-related pain. Journal of Palliative Care 7:44-46, 1991
286. Sloman R,
Brown P, Aldana E, Chee E: The use of relaxation for the promotion of comfort
and pain relief in persons with advanced cancer [see comments]. Contemporary
Nurse 3:6-12, 1994
287. Smith KA,
Frank E: Stereotaxic placement of a ventricular catheter and reservoir for the
administration of morphine sulfate. Axone 13:12-15, 1991
288. Spiegel D,
Bloom JR: Group therapy and hypnosis reduce metastatic breast carcinoma pain.
Psychosomatic Medicine 45:333-339, 1983
289. Spiegel D,
Bloom JR, Kraemer HC, Gottheil E: Effect of psychosocial treatment on survival
of patients with metastatic breast cancer [see comments]. Lancet 2:888-891,
1989
290. Squier R,
Morrow JS, Roman R: Pain therapy for pancreatic carcinoma with neurolytic
celiac plexus block. Connecticut Medicine 53:269-271, 1989
291. Stambaugh
J, Drew J: A double-blind parallel evaluation of the efficacy and safety of a
single dose of ketoprofen in cancer pain. Journal Of Clinical Pharmacology
28:S34-9, 1988
292. Stambaugh
JEJ, Sarajian C: Analgesic efficacy of zomepirac sodium in patients with pain
due to cancer. Journal Of Clinical Pharmacology 21:501-507, 1981
293. Stoll HR:
Effective pain control in cancer patients in the home care setting. Recent
Results In Cancer Research 121:36-42, 1991
294. Stovner J,
Endresen R: Intrathecal phenol for cancer pain. Acta Anaesthesiologica
Scandinavica 16:17-21, 1972
295. Stuart G,
Cramond T: Role of percutaneous cervical cordotomy for pain of malignant
origin. Medical Journal of Australia 158:667-670, 1993
296. Stuart GJ,
Davey EB, Wight SE: Continuous intravenous morphine infusions for terminal pain
control: a retrospective review. Drug Intelligence & Clinical Pharmacy
20:968-972, 1986
297. Su CF, Liu
MY, Lin MT: Intraventricular morphine produces pain relief, hypothermia,
hyperglycaemia and increased prolactin and growth hormone levels in patients
with cancer pain. Journal Of Neurology 235:105-108, 1987
298. Swanson G,
Smith J, Bulich R, New P, Shiffman R: Patient-controlled analgesia for chronic
cancer pain in the ambulatory setting: a report of 117 patients. Journal of
Clinical Oncology 7:1903-1908, 1989
299. Swerdlow M:
Intrathecal phenol for cancer pain. Anaesthesia 28:297-301, 1973
300. Syrjala KL,
Cummings C, Donaldson GW: Hypnosis or cognitive behavioral training for the
reduction of pain and nausea during cancer treatment: a controlled clinical
trial [see comments]. Pain 48:137-146, 1992
301. Takagi Y,
Koyama T, Yamamoto Y: Subarachnoid neurolytic block with 15% phenol glycerine
in the treatment of cancer pain. Pain supp 4:s133, 1995(Abstract)
302. Takeda F:
Results of field testing in Japan WHO draft interim guidelines on relief of
cancer pain. Pain-Clinic 1:83-89, 1986(Abstract)
303. Takeda F,
Fujii T, Uki J, Fuse Y, Tozawa R, Kitani Y, Fujita T: Cancer pain relief and
tumor regression by means of pituitary neuroadenolysis and surgical
hypophysectomy. Neurologia Medico-Chirurgica 23:41-49, 1983
304. Takeda F,
Uki J, Fuse Y, Kitani Y, Fujita T: The pituitary as a target of antalgic treatment
of chronic cancer pain: a possible mechanism of pain relief through pituitary
neuroadenolysis. Neurological Research 8:194-200, 1986
305. Tanelian
DL, Cousins MJ: Failure of epidural opioid to control cancer pain in a patient
previously treated with massive doses of intravenous opioid. Pain 36:359-362,
1989
306. Thompson
GE, Moore DC, Bridenbaugh LD, Artin RY: Abdominal pain and alcohol celiac
plexus nerve block. Anesthesia & Analgesia 56:1-5, 1977
307. Time P,
Brown RS: When the cancer patient presents intractable pain. A new method for
managing the chronic/acute pain complex. American Journal of Hospice Care
3:28-32, 1986
308. Tong D,
Gillick L, Hendrickson FR: The palliation of symptomatic osseous metastases:
final results of the Study by the Radiation Therapy Oncology Group. Cancer
50:893-899, 1982
309. Twycross
RG: Pruritus and pain in en cuirass breast cancer [letter]. Lancet 2:696, 1981
310. Vainio A,
Tigerstedt I: Opioid treatment for radiating cancer pain: oral administration
vs. epidural techniques. Acta Anaesthesiologica Scandinavica 32:179-185, 1988
311. Van Dongen
RT, Crul BJ, De Bock M: Long-term intrathecal infusion of morphine and
morphine/bupivacaine mixtures in the treatment of cancer pain: a retrospective
analysis of 51 cases. Pain 55:119-123, 1993
312. van
Holten-Verzantvoort AT, Zwinderman AH, Aaronson NK, Hermans J, vanEmmerik B,
van Dam FS, van den Bos B, Bijvoet OL, Cleton FJ: The effect of supportive
pamidronate treatment on aspects of quality of life of patients with advanced
breast cancer. European Journal of Cancer 27:544-549, 1991
313. Vanier MC,
Labrecque G, Lepage-Savary D, Poulin E, Provencher L: Comparison of
hydromorphone continuous subcutaneous infusion and basal rate subcutaneous
infusion plus PCA in cancer pain: a pilot study. Pain 53:27-32, 1993
314. Vargha ZO,
Glickman AS, Boland J: Single-dose radiation therapy in the palliation of
metastatic disease. Radiology 93:1181-1184, 1969
315. Vecht CJ,
Hoff AM, Kansen PJ, de Boer MF, Bosch DA: Types and causes of pain in cancer of
the head and neck. Cancer 70:178-184, 1992
316. Ventafridda
GV, Caraceni AT, Sbanotto AM, Barletta L, De Conno F: Pain treatment in cancer
of the pancreas. European Journal of Surgical Oncology 16:1-6, 1990
317. Ventafridda
V, De Conno F, Panerai AE, Maresca V, Monza GC, RipamontiC. Non-steroidal
anti-inflammatory drugs as the first step in cancer pain therapy: double-blind,
within-patient study comparing nine drugs. Journal of International Medical
Research 18:21-29, 1990
318. Ventafridda
V, De Conno F, Ripamonti C, Gamba A, Tamburini M: Quality-of-life assessment
during a palliative care programme [see comments]. Annals of Oncology
1:415-420, 1990
319. Ventafridda
V, De Conno F, Vigano A, Ripamonti C, Gallucci M, GambaA. Comparison of home
and hospital care of advanced cancer patients. Tumori 75:619-625, 1989
320. Ventafridda
V, Ripamonti C, Bianchi M, Sbanotto A, De Conno F: A randomized study on oral
administration of morphine and methadone in the treatment of cancer pain.
Journal of Pain & Symptom Management 1:203-207, 1986
321. Ventafridda
V, Ripamonti C, De Conno F, Bianchi M, Pazzuconi F, Panerai AE: Antidepressants
increase bioavailability of morphine in cancer patients [letter]. Lancet
1:1204, 1987
322. Ventafridda
V, Ripamonti C, De Conno F, Tamburini M, Cassileth BR: Symptom prevalence and
control during cancer patients' last days of life [see comments]. Journal of
Palliative Care 6:7-11, 1990
323. Ventafridda
V, Tamburini M, Caraceni A, De Conno F, Naldi F: A validation study of the WHO
method for cancer pain relief. Cancer 59:850-856, 1987
324. Ventafridda
V, Tamburini M, Selmi S, Valera L, De Conno F: The importance of a home care
program for patients with advanced cancer pain. Tumori 71:449-454, 1985
325. Vijayaram
S, Bhargava K, Ramamani., Chandrasekhar., Sudharshan.Heranjal R, Lobo B:
Experience with oral morphine for cancer pain relief. Journal of Pain &
Symptom Management 4:130-134, 1989
326. Wahner HW,
Kyle RA, Beabout JW: Scintigraphic evaluation of the skeleton in multiple
myeloma. Mayo Clinic Proceedings 55:739-746, 1980
327. Waldman SD,
Feldstein GS, Allen ML, Landers M, Turnage G: Cervical epidural implantable
narcotic delivery systems in the management of upper body cancer pain.
Anesthesia & Analgesia 66:780-782, 1987
328. Walker VA,
Hoskin PJ, Hanks GW, White ID: Evaluation of WHO analgesic guidelines for
cancer pain in a hospital-based palliative care unit. Journal Of Pain And
Symptom Management 3:145-149, 1988
329. Walsh M,
Brescia FJ: Clinitron therapy and pain management in advanced cancer patients.
Journal Of Pain And Symptom Management 5:46-50, 1990
330. Walsh TD,
Saunders CM: Hospice care: the treatment of pain in advanced cancer. Recent
Results in Cancer Research 89:201-211, 1984
331. Wang JK:
Pain relief by intrathecally applied morphine in man. Anesthesiology
50/2:149-154, 1979
332. Wang JK:
Intrathecal morphine for intractable pain secondary to cancer of pelvic organs.
Pain 21:99-102, 1985
333. Ward SE,
Goldberg N, Miller-McCauley V, Mueller C, Nolan A, Robbins A, Stormoen D,
Weissman DE: Patient-related barriers to management of cancer pain. Pain
52:319-324, 1993
334. Waterman
NG, Hughes S, Foster WS: Control of cancer pain by epidural infusion of
morphine. Surgery 110:612-4; discussion 614, 1991
335. Watson PN,
Evans RJ: Intractable pain with lung cancer. Pain 29:163-173, 1987
336. Weigl K,
Mundinger F, Chrubasik J: Continuous intraventricular morphine- or
peptide-infusion for intractable cancer pain. Acta Neurochirurgica -
Supplementum 39:163-165, 1987
337. Wen HL,
Mehal ZD, Ong BH, Ho WK: Treatment of pain in cancer patients by intrathecal
administration of dynorphin. Peptides 8:191-193, 1987
338. Wenk R,
Diaz C, Echeverria M, Aparicio A, Bertucelli N, Courtalon M, De Felipe M,
Ocariz J, Cl'erici M, Pacini T: Argentina's WHO Cancer Pain Relief Program: a
patient care model. Journal Of Pain And Symptom Management 6:40-43, 1991
339. Wermeling
DP, Foster TS, Record KE, Chalkley JE: Drug delivery for intractable cancer
pain. Use of a new disposable parenteral infusion device for continuous
outpatient epidural narcotic infusion. Cancer 60:875-878, 1987
340. Wilkinson
TJ, Robinson BA, Begg EJ, Duffull SB, Ravenscroft PJ: Pharmacokinetics and
efficacy of rectal versus oral sustained-release morphine in cancer patients.
Cancer Chemotherapy & Pharmacology 31:251-254, 1992
341. Willox JC,
Corr J, Shaw J, Richardson M, Calman KC: Prednisolone as an appetite stimulant
in patients with cancer. British Medical Journal 288:27, 1984
342.
Yablonski-Peretz T, Klin B, Beilin Y, Warner E, Baron S, Olshwang D: Continuous
epidural narcotic analgesia for intractable pain due to malignancy. Journal of
Surgical Oncology 29:8-10, 1985
343. Yajnik S,
Singh GP, Singh G, Kumar M: Phenytoin as a coanalgesic in cancer pain. Journal
of Pain & Symptom Management 7:209-213, 1992
344. Yanagida H,
Corssen G, Trouwborst A, Erdmann W: Relief of cancer pain in man:
alcohol-induced neuroadenolysis vs. electrical stimulation of the pituitary
gland. Pain 19:133-141, 1984
345. Yoshii N,
Mizokami T, Ushikubo T, Kuramitsu T, Fukuda S: Long-term follow-up study after
pulvinotomy for intractable pain. Applied Neurophysiology 43:128-132, 1980
346. Zech D,
Dauer HG, Stollenwerk B, Lehmann KA: PCA and TTS fentanyl in the treatment of
cancer pain. Pain supp 5:s356, 1990(Abstract)
347. Zech DF,
Grond SU, Lynch J, Dauer HG, Stollenwerk B, Lehmann KA: Transdermal fentanyl
and initial dose-finding with patient-controlled analgesia in cancer pain. A
pilot study with 20 terminally ill cancer patients. Pain 50:293-301, 1992
348. Zeltzer L,
LeBaron S: Hypnosis and nonhypnotic techniques for reduction of pain and
anxiety during painful procedures in children and adolescents with cancer.
Journal of Pediatrics 101:1032-1035, 1982
349. Zenz M:
Epidural opiates for the treatment of cancer pain. Recent Results In Cancer
Research 89:107-114, 1984
350. Zenz M,
Piepenbrock S, Tryba M: Epidural opiates: long-term experiences in cancer pain.
Klinische Wochenschrift 63:225-229, 1985